Chemical Compound

Capreomycin IB

CAS Registry Number 33490-33-4
Back to search Request a Quote
Capreomycin IB chemical structure
Primary Record

Capreomycin IB

In stock
4,398 g
Purity
98.6 %
CAS
33490-33-4

Compound Identifiers & Properties

CAS
33490-33-4
PubChem CID
135508550
SMILES
C[C@H]1C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCNC(=N2)N)CNC(=O)C[C@H](CCCN)N
Canonical SMILES
C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@H]([C@H]2CCNC(N)=N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC1=O

Names & Synonyms

  • Capreomycin IB
  • UNII-2YP3RYC823
  • Capreomycin IA, 6-L-alanine
  • AC1MHWTI
  • 2YP3RYC823
  • CAPREOMYCIN IB [MI]
  • RefChem:123294
  • DTXSID4046652
  • BRN 1208633
  • CAPREOMYCIN IB [WHO-IP]
  • DTXCID801030480
  • CHEMBL4074922
  • C25H44N14O7
  • Tox21_112477
  • Tox21_113062
  • Tox21_112477_1
  • C25-H44-N14-O7
  • CID3034057
  • NCGC00163522-01
  • NCGC00167473-01
  • NCGC00167473-02
  • LS-48802
  • 33490-33-4
  • CAS-33490-33-4
  • (3S)-3,6-DIAMINO-N-(((2S,5S,8Z,11S,15S)-15-AMINO-11-((4R)-2-AMINO-1,4,5,6-TETRAHYDROPYRIMIDIN-4-YL)-8-((CARBAMOYLAMINO)METHYLENE)-2-METHYL-3,6,9,12,16-PENTAOXO-1,4,7,10,13-PENTAAZACYCLOHEXADECAN-5-YL)METHYL)HEXANAMIDE
  • CYCLO((2S)-2-AMINO-.BETA.-ALANYL-L-ALANYL-3-(((3S)-3,6-DIAMINO-1-OXOHEXYL)AMINO)-L-ALANYL-(2Z)-3-((AMINOCARBONYL)AMINO)-2,3-DIDEHYDROALANYL-(2S)-2-((4R)-2-AMINO-3,4,5,6-TETRAHYDRO-4-PYRIMIDINYL)GLYCYL)
  • (3R)-3,6-diamino-N-(((2S,5S,8Z,11S,15S)-15-amino-11-((6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-((carbamoylamino)methylidene)-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl)methyl)hexanamide
  • (3R)-3,6-Diamino-N-(((2S,5S,8Z,11S,15S)-15-amino-3,6,9,12,16-pentahydroxy-8-(((C-hydroxycarbonimidoyl)amino)methylidene)-11-((4R)-2-imino-1,3-diazinan-4-yl)-2-methyl-1,4,7,10,13-pentaazacyclohexadeca-1(16),3,6,9,12-pentaen-5-yl)methyl)hexanimidate
  • (3R)-3,6-diamino-N-[[(2S,5S,8Z,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide
  • (3R)-3,6-Diamino-N-{[(2S,5S,8Z,11S,15S)-15-amino-3,6,9,12,16-pentahydroxy-8-{[(C-hydroxycarbonimidoyl)amino]methylidene}-11-[(4R)-2-imino-1,3-diazinan-4-yl]-2-methyl-1,4,7,10,13-pentaazacyclohexadeca-1(16),3,6,9,12-pentaen-5-yl]methyl}hexanimidate
  • (3S)-3,6-diamino-N-(((2S,5S,8E,11S,15S)-15-amino-11-((4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-8-((carbamoylamino)methylidene)-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl)methyl)hexanamide
  • (3S)-3,6-Diamino-N-({(2S,5S,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl}methyl)hexanamide
  • (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide
  • (3S)-3,6-diamino-N-[[(2S,5S,8Z,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide
  • 3,6-Diamino-hexanoic acid {(2S,5S,11S,15S)-15-amino-11-(2-imino-hexahydro-pyrimidin-4-yl)-2-methyl-3,6,9,12,16-pentaoxo-8-[1-ureido-meth-(Z)-ylidene]-1,4,7,10,13-pentaaza-cyclohexadec-5-ylmethyl}-amide
  • CYCLO((2S)-2-AMINO-BETA-ALANYL-L-ALANYL-3-(((3S)-3,6-DIAMINO-1-OXOHEXYL)AMINO)-L-ALANYL-(2Z)-3-((AMINOCARBONYL)AMINO)-2,3-DIDEHYDROALANYL-(2S)-2-((4R)-2-AMINO-3,4,5,6-TETRAHYDRO-4-PYRIMIDINYL)GLYCYL)